Premier Fund Managers Ltd Makes New $918,000 Investment in Astrana Health, Inc. (NASDAQ:ASTH)

Premier Fund Managers Ltd acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 16,234 shares of the company’s stock, valued at approximately $918,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. SteelPeak Wealth LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $39,398,000. NorthCrest Asset Manangement LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $26,704,000. Principal Financial Group Inc. acquired a new position in shares of Astrana Health in the 3rd quarter valued at $13,383,000. F M Investments LLC purchased a new stake in shares of Astrana Health during the 3rd quarter valued at $11,738,000. Finally, Diamond Hill Capital Management Inc. acquired a new stake in shares of Astrana Health during the 3rd quarter worth $8,245,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Stifel Nicolaus boosted their price target on Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Truist Financial raised their target price on Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. TD Cowen initiated coverage on Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company. Finally, Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $65.17.

Astrana Health Trading Up 1.0 %

Shares of ASTH opened at $40.93 on Wednesday. Astrana Health, Inc. has a one year low of $32.04 and a one year high of $63.20. The stock has a 50-day moving average price of $54.77 and a 200 day moving average price of $47.86. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market capitalization of $2.30 billion, a P/E ratio of 31.48, a P/E/G ratio of 1.89 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the prior year, the business posted $0.47 EPS. Sell-side analysts forecast that Astrana Health, Inc. will post 1.17 EPS for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.